| J9144 | Injection, daratumumab, 10 mg and hyaluronidase‑fihj | 5,040 | $40 | $191.5K |
| J9271 | Injection, pembrolizumab, 1 mg | 4,400 | $40 | $189.2K |
| J9299 | Injection, nivolumab, 1 mg | 7,060 | $20 | $169.3K |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 1,930 | $40 | $69.5K |
| 99232 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or… | 230 | $70 | $14.9K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 100 | $110 | $11.1K |
| 99233 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 80 | $100 | $8.2K |
| J9041 | Injection, bortezomib, 0.1 mg | 1,050 | $10 | $5.2K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 40 | $150 | $5.2K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 20 | $180 | $4.4K |